Michael Sinclair is Director & 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT). They have made 7 open-market trades across 1 company since 2015, most recently 2023-03-02.
CIK 0001551246
1 open-market purchase totalling $25K since 2017, against 6 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 67% | 83% |
| Avg Move | +5.8% | +11.0% | +7.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPNT | SELL | 2022-06-13 | 2022-06-15 | $10.97 | $289K | +5.4% | -2.8% | -1.3% |
| OPNT | SELL | 2022-06-09 | 2022-06-13 | $12.25 | $97K | +13.0% | +6.1% | -1.8% |
| OPNT | SELL | 2022-06-06 | 2022-06-08 | $12.94 | $209K | -11.3% | -4.0% | -10.3% |
| OPNT | SELL | 2022-06-02 | 2022-06-06 | $13.73 | $549K | -5.2% | -5.6% | -11.5% |
| OPNT | SELL | 2021-08-23 | 2021-08-25 | $15.49 | $3.6M | +25.4% | +77.5% | +75.6% |
| OPNT | SELL | 2019-09-12 | 2019-09-13 | $12.52 | $751K | +7.7% | -5.1% | -5.9% |
| OPNT | BUY | 2017-01-17 | 2017-01-17 | $7.01 | $25K | +103.8% | +12.9% | +12.9% |
| LLTP | SELL · Routine | 2015-01-15 | 2015-12-03 | $3.50 | $6K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.